UK Pro-Innovation Report Offers Promise For Medtech With MHRA/NICE Alignment

IDAP medtech innovation pathway set for launch in 2023

Report to government underlines need for faster, parallel evaluation of medtech and healthtech innovation and recommends bigger role for MHRA alongside work done by approved bodies on UKCA file processing.

Finger about to press a start button with the word innovation on the left.
• Source: Shutterstock

After a brief news lull around medtech regulatory system changes for the UK, the government and Medicines and Healthcare products Regulatory Agency (MHRA) issued several updates on new structures and access to medtech and healthtech in late May.

Among them was the government’s response to the chief scientific advisor’s (CSA) report on the pro-innovation regulation of emerging life science technologies, with a strong focus on advancing medtech.

Key Takeaways
  • MHRA asked to work alongside approved bodies on UKCA approvals

  • Pilot launch of IDAP set for later in 2023...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Europe